Related Experiment Video
Updated: May 18, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Novel Mutations in FA2H-Associated Neurodegeneration: An Underrecognized Condition?
Rosemarie Rupps1, Juliette Hukin, Martha Balicki
11Department of Medical Genetics, University of British Columbia, Canada.
Journal of Child Neurology
|September 12, 2012
Summary
FA2H gene mutations cause rare neurodegenerative disorders like spastic paraplegia. This study identifies two new FA2H mutations in a child, highlighting the need for broader genetic testing in pediatric neurodegeneration.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Hereditary spastic paraplegias (HSPs) are a group of genetically diverse neurological disorders that can be challenging to diagnose clinically.
- The FA2H gene is linked to autosomal recessive neurodegenerative conditions, including spastic paraplegia (with or without dystonia) and demyelinating leukodystrophy.
- Mutations in the FA2H gene are infrequently reported, suggesting potential underdiagnosis.
Purpose of the Study:
- To report a novel case of FA2H-associated neurodegeneration in a child.
- To highlight the clinical and genetic features of this rare disorder.
- To emphasize the importance of considering FA2H mutations in pediatric neurodegeneration.
Main Methods:
- Clinical evaluation of a 5-year-old girl with progressive lower limb spasticity and periventricular leukomalacia.
- Genetic analysis to identify mutations in the FA2H gene.
- Review of magnetic resonance imaging (MRI) findings.
Main Results:
- The patient was found to have two novel mutations in the FA2H gene in compound heterozygosity (p.S70L/p.P323L).
- The clinical presentation and MRI findings were consistent with FA2H-associated neurodegeneration.
- This case expands the known spectrum of FA2H-related disorders and their ethnic diversity.
Conclusions:
- FA2H-associated neurodegeneration may be underrecognized, particularly in children from diverse ethnic backgrounds presenting with neurodegeneration.
- MRI findings are crucial diagnostic clues for FA2H disorders and other hereditary spastic paraplegias.
- Early diagnosis of FA2H-associated disorders is vital for accurate prognosis and genetic counseling.
More Related Videos
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...